0001628279-26-000298 Sample Contracts
ContractWarrant Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
MICROTRANSPONDER, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
Pursuant to the award summary tab (the “Grant Notice”) on the website to which this Restricted Stock Purchase Agreement (this “Agreement”) is associated, MicroTransponder, Inc., a Delaware corporation (the “Company”), has granted to the holder set forth in the Grant Notice (the “Purchaser”) the right to purchase the number of shares of the Company’s Common Stock set forth in the Grant Notice (the “Shares”) at the purchase price set forth in the Grant Notice (the “Stock Purchase Right”) under the Company’s 2022 Equity Incentive Plan (the “Plan”). By his or her electronic acceptance of the Stock Purchase Right on the Grant Notice, Purchaser agrees to be bound by the terms and conditions of the Plan, this Agreement and the Grant Notice. Purchaser has reviewed this Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to accepting the Stock Purchase Right and fully understands the provisions of the Grant Notice, this Agreem
AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (this “Agreement” or “Shareholders’ Agreement”) dated as of March 5, 2025 (the “Effective Date”), by and among MicroTransponder, Inc., a Delaware corporation (the “Corporation”), and the Shareholders (as hereinafter defined).
ContractConvertible Promissory Note • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED, OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION FROM REGISTRATION. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE, OR HYPOTHECATION OTHERWISE COMPLIES WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
VENTURE LOAN AND SECURITY AGREEMENTVenture Loan and Security Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Connecticut
Loan A [Tr 1] Commitment Amount: $3,750,000 Loan A Commitment Termination Date: December 31, 2023 Loan B [Tr 1] Commitment Amount: $3,750,000 Loan B Commitment Termination Date: December 31, 2023 Loan C [Tr 2] Commitment Amount: $3,750,000 Loan C Commitment Termination Date: December 31, 2024 Loan D [Tr 2] Commitment Amount: $3,750,000 Loan D Commitment Termination Date: December 31, 2024 Loan E [Tr 3] Commitment Amount: $3,750,000 Loan E Commitment Termination Date: June 30, 2025 Loan F [Tr 3] Commitment Amount: $3,750,000 Loan F Commitment Termination Date: June 30, 2025 Loan G [Tr 4] Commitment Amount: $3,750,000 Loan G Commitment Termination Date: December 31, 2025 Loan H [Tr 4] Commitment Amount: $3,750,000 Loan H Commitment Termination Date: December 31, 2025
MICROTRANSPONDER, INC. AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) dated as of March 5, 2025, is entered into by and between MicroTransponder, Inc., a Delaware corporation (the “Company”), and the Shareholders, as defined below.
MICROTRANSPONDER, INC. STOCK OPTION AGREEMENTStock Option Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
Pursuant to the option grant summary tab (“Grant Notice”) on the website to which this Stock Option Agreement (this “Agreement”) is associated, MicroTransponder, Inc. (the “Company”) has granted to the option holder set forth in the Grant Notice (“Participant”) an option (the “Option”) under the Company’s 2022 Equity Incentive Plan (the “Plan”) to purchase the number of shares of Common Stock (the “Shares”) indicated in the Grant Notice. By his or her electronic acceptance of this Option on the Grant Notice, Participant agrees to be bound by the terms and conditions of the Plan, this Agreement and the Grant Notice. Participant has reviewed this Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to accepting the Option and fully understands all provisions of the Grant Notice, this Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Admini
SECOND AMENDED and RESTATED LICENSE AGREEMENTLicense Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Texas
Effective as of April 28, 2014 (“EFFECTIVE DATE”), THIS Agreement (“Agreement”) is between the Board of Regents (“BOARD”) of The University of Texas System (“SYSTEM”), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas at Dallas (“UTD”), a component institution of SYSTEM and MicroTransponder Inc, a corporation having its principal offices at 2802 Flintrock Trace, Austin, Texas 78738 (which hereinafter is referred to as “LICENSEE”) agree as follows.
MICROTRANSPONDER, INC. NOTE PURCHASE AGREEMENTNote Purchase Agreement • March 11th, 2026 • Mobia Medical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), is made effective as of January 30, 2026, by and among MicroTransponder, Inc., a Delaware corporation (the “Company”), and the Persons (each, a “Purchaser” and together, the “Purchasers”) listed on Exhibit A attached to this Agreement (the “Schedule of Purchasers”).